Pharmaceutical News

RSS

Are US prescription drug prices 10 times those of other nations? Only sometimes

Sen. Bernie Sanders (I-Vt.), whether in Congress or as a presidential candidate, has always taken strong positions against the high cost of prescription drugs.

19 May 2023

Obesity undermines COVID-19 vaccines

Researchers examine the impact of obesity on COVID-19 outcomes and the effectiveness of vaccines in individuals with obesity. Using data from Scotland, the study explores the relationship between body mass index (BMI) and hospitalization/mortality due to COVID-19.

15 May 2023

UArizona Health Sciences researchers seek to improve opioid therapy while decreasing its side effects

University of Arizona Health Sciences researchers are taking the foot off the brake in their quest to improve opioid therapy while decreasing its side effects.

15 May 2023

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Researchers discuss the use of endo-lysosome-targeted nanoparticles for delivering antiviral therapy to treat coronavirus infections.

15 May 2023

COVID-19 that occurs after vaccination carries a much lower risk of severe illness

COVID-19 vaccination associated with lower rates of ICU admission and in-hospital mortality during the dominance of the Delta and Omicron variants.

11 May 2023

The crisis is officially ending, but covid confusion lives on

The formal end May 11 of the national public health emergency for covid-19 will usher in lots of changes in the way Americans get vaccines, treatment, and testing for the coronavirus.

11 May 2023

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

The Medicines for All Institute at Virginia Commonwealth University will work on 14 new global health projects and expand its capabilities to improve access to medicines around the world thanks to an $18.7 million grant from the Bill & Melinda Gates Foundation.

11 May 2023

PBMs, the brokers who control drug prices, finally get Washington’s attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it.

11 May 2023

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Research compares the durability of neutralizing antibody responses among recipients of three different COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) over a period of 6 months.

11 May 2023

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

In a recent article published in the journal Science Immunology, researchers in the United States performed a longitudinal cohort study in a golden hamster model to investigate the sensory-altering mechanisms induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared to an influenza A virus (IAV).

11 May 2023

What are the potential consequences of unchecked AI proliferation?

Research paper discusses the potential threats posed by artificial intelligence (AI) to human health and well-being, including control and manipulation of people, dehumanizing lethal weapon capacity, and rendering human labor obsolete. It also highlights the need for effective regulation and calls for a moratorium on the development of self-improving AI.

11 May 2023

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Researchers explore the efficacy of current approaches to reduce the risk of cardiovascular events in patients with type 2 diabetes.

10 May 2023

Different statin drugs exert different effects on COVID-19 patients

We've all recently gotten a crash-course in drug repurposing, thanks to near-daily news reports about efforts to identify existing medicines that could help treat COVID-19 in the early phase of the pandemic.

9 May 2023

Study: Spike in the price of gout drug colchicine linked to lower use and worse disease control

Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011.

9 May 2023

Game-changers reshaping our world: From mRNA vaccines to AI-powered medicine

The paper covers recent breakthroughs in science and technology that can bring immediate and long-term changes to human life while prioritizing sustainability.

8 May 2023

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Research paper reports the results of a phase 3 clinical trial evaluating the efficacy and safety of the FINLAY-FR-2 and FINLAY-FR-1A vaccines in Iranian adults.

7 May 2023

New guidance recommends the discontinuation of antibiotics after closure of incisions

Antibiotics administered before and during surgery should be discontinued immediately after a patient's incision is closed, according to updated recommendations for preventing surgical site infections.

5 May 2023

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

In a recent study published in the JAMA Network Open, researchers performed a systematic review and meta-analysis using secondary data from 40 published studies reporting time-varying, population-level coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) estimates against laboratory-confirmed infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, Omicron or Delta, and symptomatic disease.

5 May 2023

Medical cannabis soothes cancer pain

Study evaluated the safety and effectiveness of medical cannabis in reducing pain and concurrent medications in patients with cancer. The results suggest that medical cannabis is a safe and effective complementary treatment for pain relief in patients with cancer.

4 May 2023

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

A retrospective cohort study comparing the clinical presentation and treatment outcomes of people with HIV and those without HIV who were treated with tecovirimat for confirmed mpox virus infection. The study found that HIV status did not seem to affect treatment outcomes.

4 May 2023

Previous
1
...
51
52
53
54
55
56
57
...
1433
Next

Pharmaceutical News

Are US prescription drug prices 10 times those of other nations? Only sometimes

Obesity undermines COVID-19 vaccines

UArizona Health Sciences researchers seek to improve opioid therapy while decreasing its side effects

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

COVID-19 that occurs after vaccination carries a much lower risk of severe illness

The crisis is officially ending, but covid confusion lives on

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

PBMs, the brokers who control drug prices, finally get Washington’s attention

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Researchers show the effect of SARS-CoV-2 infection on somatosensory abnormalities in a hamster model

What are the potential consequences of unchecked AI proliferation?

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Different statin drugs exert different effects on COVID-19 patients

Study: Spike in the price of gout drug colchicine linked to lower use and worse disease control

Game-changers reshaping our world: From mRNA vaccines to AI-powered medicine

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

New guidance recommends the discontinuation of antibiotics after closure of incisions

Study finds COVID-19 vaccine effectiveness against Omicron rapidly wanes over time

Medical cannabis soothes cancer pain

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News